Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg)

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 4, 2007, Pages 321-327

  Lacasa, J M ^a   Jimenez J A ^a   Ferras V ^a   Bossom, M ^a   Sola Morales O ^a   Garcia Rey C ^b   Aguilar, L ^b   Garau, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b GLAXOSMITHKLINE   (Spain)

Author keywords

amoxicillin clavulanic acid; oral infection; third mandibular molar removal

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; DIPYRONE MAGNESIUM; PLACEBO;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INFECTION RATE; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOLAR TOOTH; MOUTH INFECTION; MOUTH INFLAMMATION; OPERATION DURATION; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURGICAL RISK; SUSTAINED RELEASE FORMULATION; TOOTH EXTRACTION;

ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CASE-CONTROL STUDIES; DEGLUTITION DISORDERS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; EDEMA; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; MOLAR, THIRD; OSTEOTOMY; PAIN, POSTOPERATIVE; PLACEBOS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL WOUND INFECTION; TOOTH EXTRACTION; TREATMENT OUTCOME; TRISMUS;

EID: 33847041365     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.11.007     Document Type: Article

References (18)

1. Alcaide F., Linares J., Pallares R., Carratala J., Benitez M.A., Gudiol F., and Martin R. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 39 (1995) 2243-2247
2. Amin M.M., and Laskin D.M. Prophylactic use of indomethacin for prevention of postsurgical complications after removal of impacted third molars. Oral Surg Oral Med Oral Pathol 55 (1983) 448-451
3. Bystedt H., von Konow L., and Nord C.E. A comparison of the effect of phenoxymethylpenicillin and azidocillin on postoperative complications after surgical removal of impacted mandibular third molars. Swed Dent J 5 (1981) 225-234
4. Curran J.B., Kennett S., and Young A.R. An assessment of the use of prophylactic antibiotics in third molar surgery. Int J Oral Surg 3 (1974) 1-6
5. Flynn T.R., Shanti R.M., and Hayes C. Severe odontogenic infections, part 2: prospective outcomes study. J Oral Maxillofac Surg 64 (2006) 1104-1113
6. Happonen R.P., Backstrom A.C., and Ylipaavalniemi P. Prophylactic use of phenoxymethylpenicillin and tinidazole in mandibular third molar surgery, a comparative placebo controlled clinical trial. Br J Oral Maxillofac Surg 28 (1990) 12-15
7. Hellem S., and Nordenram A. Prevention of postoperative symptoms by general antibiotic treatment and local bandage in removal of mandibular third molars. Int J Oral Surg 2 (1973) 273-278
8. Kaziro G.S. Metronidazole (Flagyl) and Arnica Montana in the prevention of post-surgical complications, a comparative placebo controlled clinical trial. Br J Oral Maxillofac Surg 22 (1984) 42-49
9. Lloyd C.J., and Earl P.D. Metronidazole: two or three times daily-a comparative controlled clinical trial of the efficacy of two different dosing schedules of metronidazole for chemoprophylaxis following third molar surgery. Br J Oral Maxillofac Surg 32 (1994) 165-167
10. Mitchell D.A. A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery. Br Dent J 160 (1986) 284-286
11. Monaco G., Staffolani C., Gatto M.R., and Checchi L. Antibiotic therapy in impacted third molar surgery. Eur J Oral Sci 107 (1999) 437-441
12. Paterson J.A., Cardo Jr. V.A., and Stratigos G.T. An examination of antibiotic prophylaxis in oral and maxillofacial surgery. J Oral Surg 28 (1970) 753-759
13. Peterson L.J. Antibiotic prophylaxis against wound infections in oral and maxillofacial surgery. J Oral Maxillofac Surg 48 (1990) 617-620
14. Piecuch J.F., Arzadon J., and Lieblich S.E. Prophylactic antibiotics for third molar surgery: a supportive opinion. J Oral Maxillofac Surg 53 (1995) 53-60
15. Poeschl P.W., Eckel D., and Poeschl E. Postoperative prophylactic antibiotic treatment in third molar surgery--a necessity?. J Oral Maxillofac Surg 62 (2004) 3-8 discussion 9
16. Sands T, Pynn BR, Nenniger S. Third molar surgery: current concepts and controversies. Part 2. Oral Health 1993: 83: 19, 21-22, 27-30.
17. White A.R., Kaye C., Poupard J., Pypstra R., Woodnutt G., and Wynne B. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 53 (2004) i3-i20
18. Zeitler D.L. Prophylactic antibiotics for third molar surgery: a dissenting opinion. J Oral Maxillofac Surg 53 (1995) 61-64